Article
New York-The war in Iraq is being blamed for a 17% dip in attendance at the International Vision Expo East conference and exhibition, which ran March 20-23 in the first days of the conflict.
Glaukos announces several positive clinical updates for its iDose platform
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Ocugen doses first patient in phase 1 trial of OCU200 for treatment of diabetic macular edema
Inflammasome Therapeutics expands K8 trial following positive 3-month results